CoChat

γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model

Open access
Siveen, Kodappully Sivaraman, Ahn, Kwang Seok, Ong, Tina H., Shanmugam, Muthu K., Li, Feng, Yap, Wei Ney, Kumar, Alan Prem, Fong, Chee Wai, Tergaonkar, Vinay, Hui, Kam M, Sethi, Gautam · 2014 · Oncotarget
Cited by 152

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

// Kodappully Sivaraman Siveen 1,* , Kwang Seok Ahn 2,* , Tina H. Ong 3 , Muthu K. Shanmugam 1 , Feng Li 1 , Wei Ney Yap 1,4 , Alan Prem Kumar 1,4,5,6 , Chee Wai Fong 7 , Vinay Tergaonkar 8 , Kam M Hui 3,8,9,10 and Gautam Sethi 1,4 1 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 2 College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea 3 Division of Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 4 Cancer Science Institute of Singapore, Centre for Translational Medicine, 14 Medical Drive, #11-01M, Singapore 5 School of Biomedical Sciences, Faculty of Health Sciences, Curtin University, Western Australia 6009, Australia 6 Department of Biological Sciences, University of North Texas, Denton, Texas, 76203, USA 7 Davos Life Science Pte Ltd, 3 Biopolis Drive; #04-19 Synapse, Singapore 8 Institute of Molecular and Cell Biology, A*STAR, Biopolis Drive Proteos, Singapore 9 Cancer and Stem Cell Biology Program, Duke–National University of Singapore Graduate Medical School, Singapore 10 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore * contributed equally to this work Correspondence: Gautam Sethi, email: // Kam M Hui, email: // Keywords : γ-tocotrienol, HCC, angiogenesis, AKT/mTOR, orthotopic model. Received : January 6, 2014 Accepted :March 30, 2014 Published : March 31, 2014 Abstract Angiogenesis is one of the key hallmarks of cancer. In this study, we investigated whether γ-tocotrienol can abrogate angiogenesis-mediated tumor growth in hepatocellular carcinoma (HCC) and if so, through what molecular mechanisms. We observed that γ-tocotrienol inhibited vascular endothelial growth factor (VEGF)-induced migration, invasion, tube formation and viability of HUVECs in vitro . Moreover, γ-tocotrienol reduced the number of capillary sprouts from matrigel embedded rat thoracic aortic ring in a dose-dependent manner. Also, in chick chorioallantoic membrane assay, γ-tocotrienol significantly reduced the blood vessels formation. We further noticed that γ-tocotrienol blocked angiogenesis in an in vivo matrigel plug assay. Furthermore, γ-tocotrienol inhibited VEGF-induced autophosphorylation of VEGFR2 in HUVECs and also suppressed the constitutive activation of AKT/mammalian target of rapamycin (mTOR) signal transduction cascades in HUVECs as well as in HCC cells. Interestingly, γ-tocotrienol was also found to significantly reduce the tumor growth in an orthotopic HCC mouse model and inhibit tumor-induced angiogenesis in HCC patient xenografts through the suppression of various biomarkers of proliferation and angiogenesis. Taken together, our findings strongly suggest that γ-tocotrienol might be a promising anti-angiogenic drug with significant antitumor activity in HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1876

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 152

Metadata

Authors
Siveen, K. S., Ahn, K. S., Ong, T. H., Shanmugam, M. K., Li, F., Yap, W. N., Kumar, A. P., Fong, C. W., Tergaonkar, V., Hui, K. M., & Sethi, G.
Venue
Oncotarget
Published
2014-03-31
Volume
5
Issue
7
Pages
1897-1911
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1528831599
Cited by
152
References
4
FWCI
2.56
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.